Ftse Mib
34.242,49
0,75%
DAX
18.430,05
1,42%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.855,68
0,83%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CytoSorbents Corporation (CTSO) CytoSorbents Corporation (CTSO) Notizie

CytoSorbents Corporation

CTSO
0,9322
0,0022 (0,24%)
08 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/5/202423:00EDGAR2Form 8-K - Current report
02/5/202413:00GLOBECytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor..
26/4/202413:00GLOBECytoSorbents to Report First Quarter 2024 Operating and..
17/4/202413:00GLOBESTAR-T Pivotal Trial Results to Be Featured as a..
06/3/202413:00GLOBECytoSorbents to Report Fiscal 2023 Operating and Financial..
08/2/202413:00GLOBECytoSorbents to Present at the TD Cowen 44th Annual Health..
17/1/202423:20EDGAR2Form 8-K - Current report
17/1/202413:15GLOBEGroundbreaking Randomized Controlled Trial Reports Excellent..
08/1/202421:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/12/202322:49EDGAR2Form 8-K - Current report
28/12/202313:00GLOBECytoSorbents Provides Update on the STAR-T Trial and Reports..
15/12/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:15EDGAR2Form 8-K - Current report
13/12/202315:15GLOBECytoSorbents Announces Closing of $10.3 Million Registered..
11/12/202322:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/12/202322:10EDGAR2Form 8-K - Current report
09/11/202322:20EDGAR2Form 8-K - Current report
09/11/202322:15GLOBECytoSorbents Reports Third Quarter 2023 Financial and..
09/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/10/202313:00GLOBECytoSorbents to Report Third Quarter 2023 Operating and..
05/10/202313:00GLOBECytoSorbents to Present at the 8th Annual Dawson James..
27/9/202314:15EDGAR2Form 8-K - Current report
27/9/202313:00GLOBECytoSorbents Highlights Upcoming Presentations at EACTS..
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
20/9/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:30EDGAR2Form 8-K - Current report
19/9/202313:00GLOBECytoSorbents Announces Kathleen P. Bloch To Resume as..
12/9/202322:31EDGAR2Form 8-K - Current report
11/9/202317:32GLOBECytoSorb with Ex Vivo Organ Perfusion: Transforming the..
01/9/202322:43GLOBECytoSorbents Announces Resignation of Chief Financial..
01/9/202322:30EDGAR2Form 8-K - Current report
31/8/202313:00GLOBECytoSorbents Granted Expanded ANVISA Registration to Treat..
15/8/202323:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202313:00PRNUSCytoSorbents Completes U.S. and Canadian STAR-T Pivotal..
11/8/202323:30EDGAR2Form 8-K - Current report
09/8/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202322:15GLOBECytoSorbents Reports Second Quarter 2023 Financial and..
01/8/202322:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/7/202313:00GLOBECytoSorbents to Report Second Quarter 2023 Operating and..
19/7/202323:19EDGAR2Form 8-K - Current report
12/7/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,93 Min: 0,93 Max: 0,98
Chiusura: 0,93

La tua Cronologia

NASDAQ
CTSO
CytoSorbents
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network